FindTrial
Sign In

The ED 95 of Esketamine in Outpatient-Induced Abortion Compared to Equivalent Sufentanil: a randomized controlled trial

The ED 95 of Esketamine in Outpatient-Induced Abortion Compared to Equivalent Sufentanil: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056058
Enrollment
Unknown
Registered
2022-01-31
Start date
2022-01-31
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early pregnancy

Interventions

Group one:esketamine+propofol
Group two:sufentanil+propofol
Group three:propofol

Sponsors

Hangzhou Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Women in the first trimester (6-10 weeks) who planned to undergo painless abortion; 2. Women aged between 18 and 45; 3. BMI =18-25kg/m^2; 4. ASA classification was I-II; 5. Voluntary participation in the study.

Exclusion criteria

Exclusion criteria: 1. Women with obstructive sleep apnea syndrome; 2. Women with allergy or contraindication to the drugs used in this study; 3. Long-term use of opioid analgesics in women; 4. Have serious heart, lung, liver, or kidney disease.

Design outcomes

Primary

MeasureTime frame
Dose of propofol;—

Secondary

MeasureTime frame
Time of operation;Awakening time;Heart rate;Mean arterial pressure;Pluse oxygen saturation;Ramsay sedation scores;Visual analogue scale scores;Beck Depression Scale score;Adverse effect;Time of intraoperative body movements;—

Countries

China

Contacts

Public ContactQiling Jiang

Hangzhou Traditional Chinese Medicine Hospital

476848996@qq.com+86 17708339731

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026